Stepan Past Earnings Performance
Past criteria checks 2/6
Stepan has been growing earnings at an average annual rate of 2.4%, while the Chemicals industry saw earnings growing at 20.4% annually. Revenues have been growing at an average rate of 8.5% per year. Stepan's return on equity is 4.3%, and it has net margins of 2.2%.
Key information
2.4%
Earnings growth rate
2.6%
EPS growth rate
| Chemicals Industry Growth | 20.4% |
| Revenue growth rate | 8.5% |
| Return on equity | 4.3% |
| Net Margin | 2.2% |
| Next Earnings Update | 20 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Stepan makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 2,421 | 52 | 142 | 60 |
| 30 Jun 23 | 2,578 | 79 | 157 | 63 |
| 31 Mar 23 | 2,749 | 118 | 159 | 65 |
| 31 Dec 22 | 2,773 | 147 | 151 | 67 |
| 30 Sep 22 | 2,756 | 153 | 155 | 67 |
| 30 Jun 22 | 2,640 | 151 | 144 | 66 |
| 31 Mar 22 | 2,484 | 142 | 148 | 64 |
| 31 Dec 21 | 2,346 | 138 | 159 | 63 |
| 30 Sep 21 | 2,231 | 151 | 163 | 62 |
| 30 Jun 21 | 2,092 | 147 | 168 | 61 |
| 31 Mar 21 | 1,958 | 140 | 168 | 59 |
| 31 Dec 20 | 1,870 | 127 | 154 | 58 |
| 30 Sep 20 | 1,820 | 118 | 146 | 56 |
| 30 Jun 20 | 1,807 | 111 | 142 | 56 |
| 31 Mar 20 | 1,820 | 106 | 139 | 55 |
| 31 Dec 19 | 1,859 | 103 | 155 | 55 |
| 30 Sep 19 | 1,880 | 105 | 141 | 53 |
| 30 Jun 19 | 1,937 | 101 | 146 | 54 |
| 31 Mar 19 | 1,984 | 104 | 139 | 54 |
| 31 Dec 18 | 1,994 | 111 | 134 | 54 |
| 30 Sep 18 | 2,001 | 97 | 143 | 55 |
| 30 Jun 18 | 1,981 | 97 | 134 | 53 |
| 31 Mar 18 | 1,956 | 92 | 140 | 54 |
| 31 Dec 17 | 1,925 | 101 | 136 | 54 |
| 30 Sep 17 | 1,872 | 90 | 139 | 54 |
| 30 Jun 17 | 1,829 | 90 | 147 | 56 |
| 31 Mar 17 | 1,789 | 90 | 146 | 56 |
| 31 Dec 16 | 1,766 | 86 | 150 | 56 |
| 30 Sep 16 | 1,765 | 91 | 151 | 56 |
| 30 Jun 16 | 1,764 | 94 | 137 | 54 |
| 31 Mar 16 | 1,762 | 83 | 141 | 52 |
| 31 Dec 15 | 1,776 | 76 | 138 | 50 |
| 30 Sep 15 | 1,811 | 69 | 123 | 47 |
| 30 Jun 15 | 1,859 | 58 | 129 | 46 |
| 31 Mar 15 | 1,910 | 65 | 113 | 45 |
| 31 Dec 14 | 1,927 | 57 | 109 | 45 |
| 30 Sep 14 | 1,947 | 62 | 117 | 47 |
| 30 Jun 14 | 1,931 | 68 | 116 | 48 |
| 31 Mar 14 | 1,902 | 67 | 120 | 47 |
| 31 Dec 13 | 1,881 | 73 | 124 | 47 |
| 30 Sep 13 | 1,834 | 78 | 123 | 48 |
| 30 Jun 13 | 1,799 | 77 | 118 | 47 |
| 31 Mar 13 | 1,795 | 76 | 120 | 46 |
Quality Earnings: S2CL34 has high quality earnings.
Growing Profit Margin: S2CL34's current net profit margins (2.2%) are lower than last year (5.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: S2CL34's earnings have grown by 2.4% per year over the past 5 years.
Accelerating Growth: S2CL34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: S2CL34 had negative earnings growth (-65.9%) over the past year, making it difficult to compare to the Chemicals industry average (-37.2%).
Return on Equity
High ROE: S2CL34's Return on Equity (4.3%) is considered low.